You have 9 free searches left this month | for more free features.

Condition

Neovascular Age-related Macular Degeneration (3)

Overall Status

Active, not recruiting (1)

Completed (1)

Recruiting (1)

Sign in for free

Phase

phase 1/phase 2 (1)

phase 2 (1)

Sponsor

Clearside Biomedical, Inc. (3)

Collaborator

Intervention

cls-ax (3)

aflibercept (1)

anti-vegf (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (3)

Study Type

Interventional (2)

Observational (1)

cls-ax

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Neovascular Age-related Macular Degeneration Trial in Phoenix (CLS-AX, Aflibercept)

Recruiting

Neovascular Age-related Macular Degeneration

CLS-AX
Aflibercept

Phoenix, Arizona

Retinal Research Institute, LLC

Jun 4, 2023

Long-term Outcomes of Subjects in the CLS-AX CLS1002-101 Study

Active, not recruiting

Neovascular Age-related Macular Degeneration

CLS-AX

Phoenix, Arizona
+6 more

Dec 14, 2022

Neovascular Age-related Macular Degeneration Trial in United States (CLS-AX, Anti-VEGF)

Completed

Neovascular Age-related Macular Degeneration

CLS-AX
Anti-VEGF

Phoenix, Arizona
+10 more

Dec 1, 2022